China’s Xi speaks with Trump by phone, discusses Taiwan and bilateral ties
Here’s a summary of the most significant insider buys and sells disclosed on Tuesday, November 18, 2025.
Top Buys
MACH Natural Resources LP Director Tom L. Ward demonstrated strong confidence in the company by purchasing 83,370 common units valued at over $1 million. The transactions occurred on November 14 and 17, 2025, at prices ranging from $11.98 to $12.01. Specifically, Ward acquired 41,630 common units for the Tom L. Ward Family Foundation on November 14, followed by another 41,740 units on November 17 for the same foundation. These purchases come as MNR trades near its 52-week low of $11.39, with the stock down over 22% year-to-date. The company currently offers a substantial 9.13% dividend yield, which may have influenced Ward’s investment decision.
OPKO Health, INC. CEO and Chairman Phillip Frost, along with Frost Gamma Investments Trust, reported purchasing shares of OPKO Health on November 18, 2025. The purchases totaled $737,747 and included multiple acquisitions of common stock. These transactions were executed at prices ranging from $1.245 to $1.29, with a total value of $678,905. Additional shares were acquired at a price of $1.26, amounting to $58,842.
ASA Gold & Precious Metals Ltd saw ten percent owner Saba Capital Management, L.P. increase its stake in the company. According to a Form 4 filing with the Securities and Exchange Commission, Saba Capital purchased 18,124 shares of common stock at a price of $47.35 per share, for a total transaction value of $858,171. The transaction, which took place on November 17, 2025, increased Saba Capital Management’s total holdings in ASA Gold & Precious Metals Ltd to 5,201,466 shares.
Sunrise Realty Trust, Inc. Director and Executive Chairman Leonard M. Tannenbaum recently purchased shares of the company’s common stock in two transactions, acquiring a total value of $306,154. On November 14, 2025, Tannenbaum acquired 14,710 shares at a price of $9.38, with the trades executed in multiple transactions ranging from $9.33 to $9.49. Following this, on November 17, 2025, he purchased an additional 17,500 shares at $9.61, in transactions ranging from $9.56 to $9.70. These insider purchases come as the stock trades at $9.38, down nearly 28% year-to-date and at just 0.68 times book value.
McGraw Hill, Inc. Director Steven Reinemund reported purchasing 15,710 shares of common stock on November 14, 2025. The shares were bought at a weighted average price of $15.03, for a total value of $236,121. The prices paid for the shares ranged from $14.80 to $15.485. The stock has since climbed to $16.24, representing an 8% gain from Reinemund’s average purchase price. Following the transaction, Reinemund directly holds 10,882 shares and indirectly holds 15,710 shares through The Gail T Reinemund Irrevocable Trust FBO. This insider purchase comes as McGraw Hill maintains impressive gross profit margins of 80.6%, despite not being profitable over the last twelve months.
Top Sells
Cisco Systems Chair and CEO Charles Robbins sold 578,504 shares of company stock between November 14 and November 18, 2025, for approximately $46.9 million. The sales occurred at prices ranging from $76.58 to $78.95, with the stock currently trading at $77.37. The transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 6, 2025. The timing coincides with Cisco’s strong market performance, with the stock showing a 7.89% return over the last week and a 34.06% year-to-date gain.
Vistra Corp Executive Vice President & President Vistra Retail, Scott A. Hudson, sold 56,000 shares of common stock on November 14, 2025, at a weighted-average price of $168.86, for a total of $9,456,160. The prices for the sale ranged from $168.84 to $169.41. On the same day, Hudson also exercised options to acquire 56,000 shares of Vistra Corp common stock at an exercise price of $19.68, for a total value of $1,102,080.
Venture Global, Inc. Senior Vice President of Development Fory Musser sold 1,000,000 shares of Class A Common Stock, realizing approximately $8 million. The sales occurred on November 14 and 17, 2025, with prices ranging from $8.03 to $8.06 per share. Specifically, on November 14, Musser sold 223,702 shares. Then, on November 17, the Senior VP sold 776,298 shares.
Chubb Vice Chairman John J. Lupica sold 16,375 common shares of the company on November 14, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at prices ranging from $296.08 to $296.79, with an average price of $296.45, totaling $4,854,368. Following the transaction, Lupica directly owns 74,225.20 shares of Chubb. Additionally, he indirectly owns 78,700 shares through a trust for his wife and 10,000 shares through a trust for his descendants. The transaction occurred near Chubb’s current trading price of $297.89, which is within 3% of its 52-week high of $306.91.
United Therapeutics Chairperson and CEO Martine Rothblatt sold shares of the company’s common stock worth approximately $3.7 million on November 14 and November 17, 2025. The sales were executed at prices ranging from $460.34 to $468.32. The transactions involved multiple sales. On November 14, Rothblatt sold a total of 3,930 shares in a range of $460.34 to $466.05. On November 17, Rothblatt sold 4,000 shares in a price range between $466.26 and $468.32.
Why Monitor Insider Activity
Tracking insider buying and selling can provide valuable insights for investors. When corporate insiders purchase shares of their own companies, it often signals confidence in the future prospects of the business. Conversely, insider selling might indicate that those with the most intimate knowledge of a company see potential challenges ahead or simply need liquidity for personal reasons. However, it’s important to remember that insiders sell stock for various reasons unrelated to company outlook, including diversification, tax planning, or personal financial needs. For the most comprehensive picture, investors should consider insider transactions as just one factor among many when making investment decisions, and always analyze these moves within the broader context of company fundamentals, industry trends, and overall market conditions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.